Related Experiment Video

Updated: May 25, 2026

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
05:14

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

Cardiac dysfunction and pathology in the dystrophin and utrophin-deficient mouse during development of dilated

Ju Lan Chun1, Robert O'Brien, Suzanne E Berry

  • 1Department of Animal Sciences, University of Illinois at Urbana-Champaign, 3612 VMBSB, 2001 S. Lincoln Ave., Urbana, IL 61802, USA.

Neuromuscular Disorders : NMD
|January 24, 2012
PubMed

Insights

Duchenne muscular dystrophy (DMD) cardiac issues are often silent. The mdx/utrn(-/-) mouse model shows cardiac dysfunction and pathology similar to DMD dilated cardiomyopathy, offering a new research tool.

Area of Science:

  • Cardiovascular Research
  • Muscular Dystrophy Research
  • Animal Models of Disease

Background:

  • Cardiac involvement in Duchenne muscular dystrophy (DMD) is typically asymptomatic until advanced stages.
  • Limited understanding of DMD cardiac pathology evolution and scarcity of suitable animal models hinder treatment development.
  • Dystrophin and utrophin deficiency are implicated in muscular dystrophy pathogenesis.

Purpose of the Study:

  • To investigate cardiac function and pathology in dystrophin/utrophin-deficient (mdx/utrn(-/-)) mice.
  • To assess the utility of the mdx/utrn(-/-) mouse as a model for DMD-associated cardiomyopathy.

Main Methods:

  • Evaluation of cardiac function parameters including left ventricular fractional shortening and ejection fraction.
  • Assessment of cardiac structural changes such as ventricular dilation, wall thinning, and fibrosis.
  • Ultrastructural analysis of cardiac mitochondria in mdx/utrn(-/-) mice.

Main Results:

  • mdx/utrn(-/-) mice exhibited decreased left ventricular fractional shortening and ejection fraction by 15 weeks.
  • Significant left ventricle dilation, ventricular wall and septal thinning, and fibrosis were observed.
  • Mitochondrial abnormalities in organization, size, and shape were detected via ultrastructure analysis.

Conclusions:

  • The mdx/utrn(-/-) mouse model displays functional and pathological cardiac changes mirroring dilated cardiomyopathy in DMD.
  • This model represents a valuable tool for studying DMD cardiomyopathy progression and evaluating potential therapeutic strategies.

More Related Videos

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix10:21

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

Published on: June 14, 2016

Measuring Pressure Volume Loops in the Mouse09:15

Measuring Pressure Volume Loops in the Mouse

Published on: May 2, 2016

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...